Login
$FULC
$3.72 +$0.01 (0.27%) After hours

$FULC SEC Filings

Filed On Filing
16 Nov 2026 SCHEDULE 13G
16 Nov 2026 SCHEDULE 13G/A
13 Nov 2026 SCHEDULE 13G/A
13 Nov 2026 SCHEDULE 13G/A
12 Nov 2026 10-Q
12 Nov 2026 425
12 Nov 2026 8-K: Other Events

On November 7, 2026, Fulcrum Therapeutics, Inc., or Fulcrum, and Slate Medicines, Inc., or Slate, entered into an asset purchase agreement providing for the sale of Fulcrum’s early-stage fetal hemoglobin, or HbF, assets to an unaffiliate...

04 Nov 2026 EFFECT
04 Nov 2026 424B3
03 Nov 2026 S-4/A
28 Oct 2026 SCHEDULE 13G/A
27 Oct 2026 SCHEDULE 13G/A
20 Oct 2026 S-4/A
08 Oct 2026 S-4/A
02 Sep 2026 144
02 Sep 2026 S-4
17 Aug 2026 425
17 Aug 2026 425
17 Aug 2026 425
17 Aug 2026 8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +3 more

This SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of August 16, 2026, by and among Slate Medicines, Inc., a Delaware corporation (the “Company”), and each of the Persons listed on Exhibit A attached to this Agreement (eac...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support